2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of …
SM Grundy, NJ Stone, AL Bailey, C Beam, KK Birtcher… - Circulation, 2019 - Am Heart Assoc
The American Heart Association requests that this document be cited as follows: Grundy SM,
Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella …
Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella …
New and Emerging Therapies for Reduction of LDL-Cholesterol and Apolipoprotein B: JACC Focus Seminar 1/4
NS Nurmohamed, AM Navar, JJP Kastelein - Journal of the American …, 2021 - jacc.org
Adding to the foundation of statins, ezetimibe and proprotein convertase subtilisin–kexin
type 9 inhibitors (PCSK9i), novel, emerging low-density lipoprotein cholesterol (LDL-C) …
type 9 inhibitors (PCSK9i), novel, emerging low-density lipoprotein cholesterol (LDL-C) …
Bempedoic acid for primary prevention of cardiovascular events in statin-intolerant patients
Importance The effects of bempedoic acid on cardiovascular outcomes in statin-intolerant
patients without a prior cardiovascular event (primary prevention) have not been fully …
patients without a prior cardiovascular event (primary prevention) have not been fully …
Deep convolutional neural networks to predict cardiovascular risk from computed tomography
Coronary artery calcium is an accurate predictor of cardiovascular events. While it is visible
on all computed tomography (CT) scans of the chest, this information is not routinely …
on all computed tomography (CT) scans of the chest, this information is not routinely …
High-intensity statin use among patients with atherosclerosis in the US
Background Preventive therapy among patients with established atherosclerotic
cardiovascular disease (ASCVD) is generally underused. Whether new guideline …
cardiovascular disease (ASCVD) is generally underused. Whether new guideline …
Patient‐reported reasons for declining or discontinuing statin therapy: insights from the PALM registry
CK Bradley, TY Wang, S Li, JG Robinson… - Journal of the …, 2019 - Am Heart Assoc
Background Many adults eligible for statin therapy for cardiovascular disease prevention are
untreated. Our objective was to investigate patient‐reported reasons for statin …
untreated. Our objective was to investigate patient‐reported reasons for statin …
Deep learning to assess long-term mortality from chest radiographs
Importance Chest radiography is the most common diagnostic imaging test in medicine and
may also provide information about longevity and prognosis. Objective To develop and test …
may also provide information about longevity and prognosis. Objective To develop and test …
[HTML][HTML] Statins utilization trends and expenditures in the US before and after the implementation of the 2013 ACC/AHA guidelines
A Matyori, CP Brown, A Ali, F Sherbeny - Saudi Pharmaceutical Journal, 2023 - Elsevier
Importance Statins are drugs of choice in treating hyperlipidemia and preventing or reducing
cardiovascular diseases. Purpose Explore statins utilization and expenditure trends in the …
cardiovascular diseases. Purpose Explore statins utilization and expenditure trends in the …
Gaps in guideline-based lipid-lowering therapy for secondary prevention in the United States: a retrospective cohort study of 322 153 patients
BACKGROUND: Many patients with atherosclerotic cardiovascular disease (ASCVD) are not
on guideline-recommended statin therapy. We evaluated utilization of statins and other lipid …
on guideline-recommended statin therapy. We evaluated utilization of statins and other lipid …
[HTML][HTML] Therapeutic inertia in cardiovascular disease prevention: time to move the bar
DL Dixon, G Sharma, PB Sandesara, E Yang… - Journal of the American …, 2019 - jacc.org
The decline in cardiovascular (CV) mortality over the last 50 years can be largely attributed
to advances in preventive care (1). Despite these improvements, atherosclerotic …
to advances in preventive care (1). Despite these improvements, atherosclerotic …